This week the FDA officially approved a much anticipated diabetes drug that has been going through screening for quite some time. The drug was designed specifically as a type 2 diabetes treatment and according to the FDA it is now acceptable to sell to the public, which is absolutely great news for millions of diabetes sufferers. What makes Farxiga different from other medication is the way it works, rather than simply treating the issue, this new medication directly deals with the blood sugar generation system.

As a whole this is great news for anyone that suffers from type 2 diabetes. The drug has been proven to be successful, incredibly effective, and it is now going to be available to everyone. Doctors are very excited that Farxiga is now an approved medication and they’re likely to begin recommending it to a large number of patients in the very near future. Overall all type 2 diabetes patients are eligible to use the new drug and they might find that it is more effective and more affordable than current options, making it a big step forward. This is just another step forward in medicine that will likely be a big deal to millions of people around the world in the coming years.

A number of drugs that are currently used to treat diabetes has been going through studies and trials recently to determine if they have any additional medical value and according to a report released this week it looks like they might just be the next big thing in cancer treatment. The drugs are all very similar in the way they work and while they’re approved for use, the FDA keeps very tight restrictions on their usage for patients. Due to a number of preliminary studies many medical experts felt that these drugs could have an impact on cancer risk and now they’ve concluded that the drugs do in fact lower the risk of developing cancer in women.

Essentially according to doctors the drugs increase the body’s sensitivity to insulin which can reduce the risk for diabetes, since diabetes is often followed by cancer they believed this could have an impact on cancer development. After months of studies the reports concluded that the drugs did in fact have a measurable impact on cancer rates in women. Obviously it’ll be quite a while before anything like this could become a real, usable treatment, but many doctors are hopeful that this is a step in the right direction for cancer testing.

Breast cancer is one of the leading killers in much of the world, it is also the cancer that generally received the most research funding and as such doctors are hopeful there will be a treatment available soon. Well an FDA announcement this week definitely shows that some very positive progress has been made in that regard. According to the FDA, multiple patients that have been given a new drug in a trial run have shown very promising results.

This is absolutely amazing news because it is really the only step towards a successful treatment in the recent future. The drug was designed to be used as a treatment prior to surgery, making it the least invasive option and the results according to doctors were phenomenal. In the multiple trial patients across the United States the new drug was used prior to any type of surgery and it was found that the drug reduced tumor size by a noticeable amount. This is a big accomplishment according to doctors because it greatly reduces to damage when surgery is needed, plus it helps the body recover faster.

At this point the drug is obviously still experimental but doctors are hopeful that this FDA study will lead to more treatments soon. Many doctors are hopeful that a larger study will be conducted sometime this year.

The risk of developing various cancers has been difficult to understand for many people. There is seemingly no connection between any health conditions and the development of cancers. Fortunately an independent task force released a study this week that has some promising news about breast cancer development.

According to the research panel, patients that are given small doses of two leading breast cancer treatments are significantly less likely to develop the cancer in the future. The study specifically targeted women that were considered high risk and much to the surprise of the medical experts the drugs did in fact have a very significant impact. This is absolutely great news because many doctors are hopeful that with some more research they will be able to effectively create a vaccine of sorts. Any sort of advancement in the field is great news because this is the next step towards eliminating the risk for breast cancer.

Many doctors and cancer research organizations are very hopeful that this will turn into a viable vaccine system. There is also some evidence that suggests this type of pre-treatment may work for risk reduction in a number of other cancers as well. Multiple follow up studies are being conducted right now to determine how effective this could be.

Alzheimer’s disease has been affecting millions of people every single year and unfortunately there haven’t been many major breakthroughs in terms of treating, diagnosing, or preventing the disease in the past. This week, however, that has changed as a group of medical researchers announced that they may have found what will be the best test for Alzheimer’s in patients.

The studies conducted were focused primarily on brain activity and neurological effects and much to their surprise the researchers found that there are certain traits shown in the brain that eventually lead to Alzheimer’s. This is a major breakthrough because it will make it possible for doctors and neurologists to begin testing for Alzheimer’s in patients well before the onset of symptoms, making treatment much simpler.

This is great news because it means there may finally be a way to diagnose and subsequently prevent Alzheimer’s. It is not a guarantee unfortunately, but doctors say that this link is absolutely enough to at least form a basis for testing and treatment. In the future this discover will then be used to create much more in dept testing and prevention methods that would never have been created without these early detection signs. A follow up study is being conducted to see just how strongly these signals are actually linked to the development of Alzheimer’s in patients.

Cancer research is at the front of the line when it comes to medical spending and as such it is not that surprising that some significant breakthroughs have been reached. Yet another major breakthrough happened this week as a group of medical researchers discovered what may be the trick to testing and diagnosing pancreatic cancer.

The research, conducted by a number of medical experts, effectively determined the various genetic make up of a number of different pancreatic cancer samples. Like many cancers, pancreatic cancer comes in hundreds of genetic varieties, but because this research managed to completely break them down to the DNA level researchers will now be able to create a relatively effective testing routine from the information.

This is huge news not only for pancreatic cancer, but all cancers, because it will lead the field with new ways to research testing and diagnosis. The genetic sequencing and identification of pancreatic cancer and other cancers will undoubtedly lead to better treatment and medications in the future. This is a major medical breakthrough in a number of ways and nearly everyone in the medical field is incredibly happy to see this happening. Follow up studies are being planned now to determine the best way to use this information, and the same testing routines will likely be translated to other cancers as well, so it is only a matter of time before more big news comes out.

New Heart Medicine Helps Heart Heal Itself

A medical study released today by a leading health journal has shown some significant results in the area of heart health and heart treatment. A drug called thymosin beta 4 was the focus of the study and according to doctors it seems to give the human heart some preparation for repair should something go wrong.

More specifically doctors say thymosin beta 4 shows signs of aiding the heart with repairs after a major event such as a heart attack. The exact details behind how the heart is reacting to the drug are still unknown but doctors say it is a very promising result for sure.

Researchers have also confirmed that the thymosin beta 4 used in the testing has essentially proven the idea of using generic stem cells for treatment. Thymosin beta 4 was designed to attempt to make the cells in the heart begin to function more efficiently and along with that it is allegedly also helping new cells develop very rapidly in damaged areas of the heart which leads to much more rapid recovery and healthier patients.

Obviously at this time it is difficult to predict what will become of the drug though most medical analysts are very happy about the future of this drug. Numerous groundbreaking studies are being planned using this and other similar drugs and numerous leading heart research institutions hope that this could eventually develop into a significant breakthrough for heart health patients all over the world.